Wyatt Technology’s FFF-MALS Provides Efficient Liposome Characterization

(SANTA BARBARA, CALIFORNIA – (August 18 2011) - Wyatt Technology Corporation, the world leader in instrumentation for absolute macromolecular characterization and software, announces that its field flow fractionation (FFF) technology combined with multi-angle light scattering (MALS) and quasi-elastic light scattering (QELS) enables rapid measurements of particle size, size distribution, particle count, as well as structure. The combined system performs the most difficult sizing tasks in key areas of research and development in molecular biology and nanotechnology analyses, including the separation and characterization of liposomes and nanoparticles. This novel technology is illustrated in a new application note, titled “Liposome Characterization by FFF-MALS-QELS”, which is available to download free-of charge via http://www.wyatt.com/files/literature/Field_Flow_Fractionation-Liposome_Characterization.pdf.

Liposomes are made of lipid bilayers. The size of a liposome ranges from some 20 nm up to several micrometers and may be composed of one or several concentric membranes. Liposomes possess unique properties owing to the amphiphilic character of the lipids, which make them suitable for drug delivery. Liposomes have attracted considerable attention as potential vehicles for drug delivery to selected cells or tissues in vivo. Therefore, it is of great importance to monitor liposome size and encapsulation during liposome research, formulation, manufacturing and quality control. However, conventional methods to characterize liposomes fail to perform efficiently and to cover the whole size of liposomes.

In this new application note, a method combining the Wyatt Technology Eclipse FFF system with a DAWN HELEOS and online QELS was used to analyze two liposome samples, one empty, and one filled. The results demonstrated that the combined method is capable of determining the degrees of encapsulation and the internal structures of the two liposomes without making assumptions.

The FFF system offers a number of distinct advantages over column separation techniques for many applications. The method is robust and easy to use, involving minimal shearing and enabling a broad separation range, from small proteins (nm) to large particles (µm). FFF is a non-destructive technique that achieves true particle size distribution and on-line absolute characterization of a wide range of solutions and dispersions. Combined with MALS detectors, the method can determine the absolute size and molar mass distributions as well as the structure and conformation of the particles.

For more information on Wyatt Technology’s instruments or to obtain a copy of the new application note, please visit http://www.wyatt.com/ or email info@wyatt.com.

####

About Wyatt
Based in Santa Barbara, California, Wyatt Technology is the world’s leading provider of instruments for absolute macromolecular characterization. With over 40 years’ experience developing multi-angle light scattering detectors, working with customers in the biotechnology, chemical, petrochemical, pharmaceutical, academic and government arenas, Wyatt prides itself on its entrepreneurial spirit, and the uniqueness of its offerings. The Company’s groundbreaking technology and uncompromising levels of customer care make Wyatt the global hallmark in its field. For more information, please visit www.wyatt.com

For further press information please contact: Laura Browne, The Scott Partnership, 1, Whiteside, Station Road, Holmes Chapel, Cheshire, CW4 8AA, United Kingdom Tel: + 44 1477 539539 Fax: +44 1477 539540 email to:wyatt@scottpr.com

ERT Appoints Linda Deal Head of Health Outcomes Research

PHILADELPHIA, PA, 24 August 2011- ERT, a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations, announced today the appointment of Linda Deal to lead ERT’s Health Outcomes Research initiatives.  This strategic appointment extends ERT’s commitment to health outcomes research and augments its Patient Reported Outcomes capabilities and multi modality product offering with deeper scientific expertise.

Jeffrey Litwin MD, President and CEO of ERT comments, “Linda’s expertise and extensive industry knowledge will assist us in increasingly providing innovative outcomes research solutions to better serve our clients’ developing needs. Having worked inside sponsor organizations and across a number of entities within the PRO community, Linda brings insight and perspective on the creation and implementation of Patient, Clinician and Observer reported outcomes.  Her domain knowledge will enable her to add considerable value to ERT’s offerings and to our clients.”

Ms Deal brings a breadth of experience in health outcomes and in the development and validation of patient reported assessments.  Most recently she was the Immunology Patient Reported Outcomes (PRO) Lead at Janssen Pharma, a division of Johnson & Johnson, where she was responsible for developing and integrating the PRO strategy within the end to end development process. Prior to Johnson & Johnson, Linda was head of the PRO Center in Global Health Outcomes Assessment (GHOA) at Wyeth Research, now Pfizer.  She has also supported health economics and outcomes research for Wyeth, Research Triangle Institute, and Glaxo Welcome. 

Over her career, she has designed a number of assessments used in clinical trials today and has prepared over 20 regulatory briefing documents addressing PRO development and validation for supporting registration and labeling.  She now brings this wealth of experience and expertise to benefit ERT’s clients. 

In the context of health outcomes research ERT’s multi modality ePRO solutions offer the advantages of simplicity, mobility and immediacy of use over traditional paper-based methods. The company offers its customers truly independent solutions and advice providing the appropriate ePRO modality considering the complexity, length, site location, patient population, budget and size of trial.  ERT’s ePRO suite comprises an IVR solution (VIAPhone®), a digital pen (VIAPen®), a handheld device (VIAPad®) and an internet application (VIAWeb®). 

For further information on ERT and its technology and services, please email info@ERT.com , call +1 215 972 0420 or visit www.ERT.com

For further press information, please contact Neil Drake, the Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom.  Phone +44 1477 539 539, Fax +44 1477 539 540, Email ert@scottpr.com  

About ERT

ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic Patient Reported Outcomes (ePRO) in multiple modalities across all phases of clinical research.

Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties, which could cause actual results to differ materially from those expressed or implied from such statements. These risks and uncertainties include, without limitation, the Company’s ability to obtain new contracts, variability in size, scope, and duration of projects, integration of acquisitions, competitive factors, technological development, market demand, and other factors described in the Company’s filings with the Securities and Exchange Commission.  The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Thermo Fisher Scientific Launches New Robotic Autosampler for Unmatched Automation in Sample Preparation and Handling

BRUSSELS. (August 24, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific TriPlus RSH Autosampler featuring exceptional precision, flexibility and productivity in sampling solutions. Compatible with Thermo Scientific GC and GC/MS systems, the autosampler sets new standards in automation and provides advanced liquid handling cycles that enable automated functionality beyond traditional liquid, headspace and solid-phase microextraction (SPME) injections. This flexible sampling solution will be showcased at the 31st International Symposium on Halogenated Persistent Organic Pollutants – Dioxin 2011, in Brussels, Belgium, August 21 – 25, 2011.

Hello, The Scott Partnership!

I’m Lucy and I am currently in my third week of work at The Scott Partnership.  I’m here for a year on an internship after graduating in Public Relations from the University of Central Lancashire, Preston.

Although I am still getting used to setting my alarm for 7am every morning, I have to say that I am really enjoying adapting to working life.  The team here have made fitting in a breeze and have been extremely accommodating and willing to help.  I decided to take part in an internship as I feel they are a great way to get into the industry you want to be in and learn loads of useful stuff along the way.  After all, experience is one of the most essential attributes which employers in the PR industry look for.

With parts of experience within the industry here and there I can’t pretend to be an expert, However, my first few weeks here have taught me a considerable amount about how PR agencies operate, most of which I was not told in my 3 years at university! Everything from looking for and clipping coverage, posting press releases online, reaching out to editors, writing articles, researching for new clients, proof reading articles and keeping up with the company’s social media sites are included in my day to day responsibilities. That rains on whoever said interns only make the tea and coffee!

The rate in which the company is growing at a time of economic downturn makes me proud to have secured an internship here and to be able to work with a friendly, professional and experienced team. I know this year will teach me a lot and give me the experience and knowledge I need to fulfil a career within the PR industry.  The only downside is the fact I have to go for longer runs every weekend to burn off all the tea and biscuits we consume in the week- putting on a stone wasn’t in the job description!

New Pharma Application Notebook features a variety of The Scott Partnership clients.

The new edition of Pharma Application Notebook features some great coverage of The Scott Partnership and a number of our clients.  The global supplement from Pharma-Mag concentrates upon the techniques and applications used across all aspects of the pharmaceutical production process. Pharma Mag- features everything from packaging and distribution to drug discovery.

Click on the link to read cutting-edge editorial on topics such as patient recruitment, ePRO solutions for cardiac safety and the challenges of pharmaceutical-grade water monitoring.

CEO of Molecular Profiles Recognized as One of 100 Most Inspiring People in the Life Sciences Industry

(Nottingham, 5, August 2011) Molecular Profiles, a leading provider of pharmaceutical development services, announces that Nikin Patel, CEO, has been acknowledged as one of PharmaVOICE magazine’s top 100 most inspiring individuals in the life sciences industry. Dr. Patel has been recognized for his 13 years of dedicated commitment to advancing pharmaceutical technology that has seen him co-found a company infused with his own brand of innovative problem solving and new industry techniques. The PharmaVOICE 100 winners are nominated by the magazine’s readers, who identify the individuals they consider to have the most influence and positive impact on leadership, research and development, technology, creativity, marketing and business strategies.


“I feel incredibly honoured to be receiving this award,” said Dr.Patel. “But I have to add that it would not have been possible without my talented and inspiring colleagues. This award is very gratifying, and my team and I will continue the hard work to improve and add to our portfolio of services for the pharmaceutical industry.”

Thermo Fisher Scientific Launches Build-Your-Own FT-IR Microsite to Help Users Design Customized Analyzers

MADISON, Wis., (August 3, 2011) – Thermo Fisher Scientific Inc., the world leader in serving science, today announced its updated Build-Your-Own FT-IR website. The site offers many options for configuring the high-performance Thermo Scientific Nicolet 6700 FT-IR spectrometer so any laboratory can design the ideal FT-IR to meet its unique analytical challenges. This flexibility, which includes several optical component options that span the full range of applications involving infrared spectroscopy, is especially important in quality control, analytical services and research environments.

The Build-Your-Own FT-IR microsite demonstrates the versatility of the Nicolet 6700 spectrometer by matching specific sample types with component and accessory options that provide the best results. To access the site, please visit http://www.buildyourownftir.com/.

The new microsite offers users information about the function and benefits of each component. Each accessory is matched with the type of sample the customer plans to analyze, allowing them to construct an instrument with the perfect combination of components and accessories. Items can be added or removed any time during the configuration process.

Goodbye Internship

By Adam Gron, Public Relations Intern, The Scott Partnership

Right… There is no easy way to start with this reflective post so I’ll just do it: big thanks to all of you!

A few things I’ve learned during this crazy journey through the unexplored shores of PR practice at The Scott Partnership:

One: Be enthusiastic.

Two: If you are unsure about something you have to do (or feel totally lost like me during my first days) ask questions! Nothing questioned, nothing learned!

And three: Respect the people you work with. They’re the people that motivate and inspire you. At The Scott Partnership there is something about the team that has always encouraged me to run faster, work harder and face down my fears when I had to move out of the comfort zone. And that is, without doubt, the best way to learn.

But first, a little bit of background…

Prism Ideas CEO Acknowledged Among the Top 100 Most Inspiring People in the Pharmaceutical Industry

Cheshire, UK (August, 2, 2011) Prism Ideas, an independent global provider of medical communications and drug development consultancy services, today announced that Dr. James Sawyer, CEO, has been selected by PharmaVOICE magazine as one of the 100 most inspirational and influential people in the pharmaceutical industry. James has been recognised for his role in founding Prism Ideas and his sustained contribution to the advancement of pharmaceutical research, which has greatly enhanced the management and treatment options for debilitating illnesses. The PharmaVOICE 100 winners are nominated by the magazine’s readers based on the individual’s ability to inspire and positively impact on corporate leadership, research and development in the pharmaceutical industry.


“I am surprised and delighted to have been nominated to receive this prestigious award and to be listed alongside the other recipients,” James said, “At Prism Ideas we believe in putting patients and people first. The recognition represented by this award would not have been possible had I not been able to work with such innovative and pioneering individuals who share my vision of developing new strategies that advance processes within the industry to improve healthcare delivery.”

Manchester-based Analytical Technology Achieves Record Turnover as Water Industry Thrives

Manchester, UK (July 28, 2011) Specialist electrochemical sensor manufacturer Analytical Technology Inc. today announces that the company has gone from strength to strength since its inception in 1998, culminating in a record month for the business in June 2011. This spectacular achievement demonstrates the buoyancy of the current market for water monitoring instrumentation, despite the present economic recession. It is also a demonstration of the ongoing and imperative need for reliable water monitoring in the water utility industry to ensure a safe and continuous supply of water.


This year Manchester-based Analytical Technology has had its strongest first half ever and this culminated in June sales being the highest on record. A large component of the June sales, which peaked at £1.2 million for the month, can be credited to the recent contract signed by Analytical Technology with Severn Trent Water, involving the purchase of 250 Analytical Technology residual chlorine monitors in June alone. Analytical Technology is also supplying Yorkshire Water with more than 450 chlorine monitors and has enjoyed repeated success in recent years, providing instrumentation to other major utility companies such as United Utilities, Scottish Water, Thames Water, Anglian Water and South West Water.

Strong Organic Growth Fuels Acquisition for Cheshire B2B Business Marketing Agency The Scott Partnership

Cheshire based B2B business marketing agency The Scott Partnership Ltd announces its acquisition of life science PR agency Kapler Communications Ltd. The acquisition sees Kapler move into the holding company of The Scott Partnership Ltd to operate as a wholly owned stand-alone business.


The Scott Partnership confirms that its consistent organic sales growth and expanding global footprint have together fuelled the acquisition, giving a three continent footprint with offices in the USA, China and now 2 in the UK.


This acquisition marks a significant step forward for The Scott Partnership in building international centres of excellence for B2B communications, delivered globally to life sciences and healthcare, chemicals and environmental clients.

The Scott Partnership Launches Corporate Communications Practice In Line with Growth Strategy

Cheshire, UK (July, 2011) - The Scott Partnership, a leading global business-to-business PR and marketing communications consultancy based in Cheshire, UK, announces the launch of a Corporate Communications practice.

The launch of the Corporate Communications practice comes on the back of fifteen consecutive years of growth, which has seen The Scott Partnership outperform the industry. It comes one year after the successful opening of offices in both North America and China.

To lead the new division, Pat McLaren has been recruited as Corporate Communications Director. A strategy and communications expert, Pat McLaren will lead services including investor relations, crisis communication and issues management. Pat will be working at The Scott Partnership in a multifunctional capacity, offering expertise in both Corporate Communications and Healthcare. This role is supported by Pat's extensive experience in both fields, holding a proven track record in investor relations and issues and crisis management and having originally qualified as a biomedical scientist. Before joining The Scott Partnership, Pat directed communications for global organisations, major investment banks, oil companies and food & drinks. Her expertise in Healthcare was honed during her 3 years spent heading Communications and Marketing at Alder Hey Children's Hospital.